FDA actions in brief

Article

The injectable antibiotic ertapenem (Invanz, Merck) was approved by FDA to treat moderate-to-severe complicated foot infections due to indicated pathogens in patients who have diabetes without osteomyelitis

© 2023 MJH Life Sciences

All rights reserved.